Hermann-josef Gertz

Leipzig, SN, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.

Journal: JAMA neurology

Published: January 31, 2022

(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls.

(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 07, 2020

Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study.

Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study.

Journal: European journal of radiology

Published: October 28, 2019

Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease.

Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: November 08, 2018

The New Modesty.

The New Modesty.

Journal: Deutsches Arzteblatt international

Published: December 19, 2017

Individualized support for informal caregivers of people with dementia - effectiveness of the German adaptation of REACH II.

Individualized support for informal caregivers of people with dementia - effectiveness of the German adaptation of REACH II.

Journal: BMC geriatrics

Published: March 13, 2017

Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.

Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD

Published: December 17, 2016

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β.

Feasibility of in vivo 18F-florbetaben PET/MR imaging of human carotid amyloid-β.

Journal: European journal of nuclear medicine and molecular imaging

Published: October 22, 2016

Inhomogeneous distribution of Alzheimer pathology along the isocortical relief. Are cortical convolutions an Achilles heel of evolution?

Inhomogeneous distribution of Alzheimer pathology along the isocortical relief. Are cortical convolutions an Achilles heel of evolution?

Journal: Brain pathology (Zurich, Switzerland)

Published: July 05, 2016

Feasibility and acceptance of simultaneous amyloid PET/MRI.

Feasibility and acceptance of simultaneous amyloid PET/MRI.

Journal: European journal of nuclear medicine and molecular imaging

Published: May 13, 2016

Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's disease.

Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's disease.

Journal: European journal of nuclear medicine and molecular imaging

Published: November 03, 2015

The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.

The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.

Journal: Journal of Alzheimer's disease : JAD

Published: October 21, 2015

Showing 1-12 of 31

Last Updated: 09/26/2026